Literature DB >> 10232447

Hyperuricaemia in patients with right or left heart failure.

M M Hoeper1, J M Hohlfeld, H Fabel.   

Abstract

Based on the clinical observation that patients with right or left heart failure often present with hyperuricaemia, the relation between serum urate values and haemodynamic variables was studied in patients with primary pulmonary hypertension (PPH) as well as in patients with advanced ischaemic heart disease or dilated cardiomyopathy. The study was a retrospective analysis of 39 patients with PPH and 36 patients with left heart disease, examining serum urate levels in association with haemodynamic variables. Elevated urate concentrations were found in 79% of the PPH patients. There was no association between serum urate levels and mean pulmonary artery pressures, but a significant correlation was found between urate levels and the cardiac index (r=0.48; p=0.0021) and an even stronger correlation between serum urate levels and mean right atrial pressures (r=0.83; p<0.0001). A similar association was found in a subgroup of 21 PPH patients not receiving diuretics. In 36 patients with ischaemic heart disease or dilated cardiomyopathy, hyperuricaemia was present in 78% and was significantly associated with elevated right atrial pressures (r=0.40; p=0.031) and even more so with elevated left atrial pressures (r=0.55; p=0.0005) but not with the cardiac index (r=0.034; p=0.86). The data show that hyperuricaemia in patients with cardiac dysfunction is closely related to elevated right or left atrial filling pressures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232447     DOI: 10.1183/09031936.99.13368299

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

1.  Serum uric acid and cardiovascular disease.

Authors:  Adriana Iliesiu; Alexandru Campeanu; Dinu Dusceac
Journal:  Maedica (Buchar)       Date:  2010-07

Review 2.  Right ventricular failure: a novel era of targeted therapy.

Authors:  Dipanjan Banerjee; Francois Haddad; Roham T Zamanian; Jayan Nagendran
Journal:  Curr Heart Fail Rep       Date:  2010-12

Review 3.  Biomarkers in pulmonary arterial hypertension.

Authors:  Julie L Rosenthal; Miriam S Jacob
Journal:  Curr Heart Fail Rep       Date:  2014-12

4.  Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.

Authors:  Shaji K Kumar; Morie A Gertz; Martha Q Lacy; David Dingli; Suzanne R Hayman; Francis K Buadi; Kristen Short-Detweiler; Steven R Zeldenrust; Nelson Leung; Philip R Greipp; John A Lust; Stephen J Russell; Robert A Kyle; S Vincent Rajkumar; Angela Dispenzieri
Journal:  Mayo Clin Proc       Date:  2011-01       Impact factor: 7.616

5.  Uric Acid as a potential biomarker of pulmonary arterial hypertension in patients with sickle cell disease.

Authors:  Keval Joshi; Fatima Anjum; Satish Gowda; Dushyant Damania; Suzette Graham-Hill; Peter Gillette; Joe Zein; Ghassan Jamaleddine; Spiro Demetis; Raj Wadgaonkar
Journal:  Indian J Hematol Blood Transfus       Date:  2011-06-08       Impact factor: 0.900

6.  Relationship between serum uric acid levels and ventricular function in patients with idiopathic pulmonary hypertension.

Authors:  Chun-Yan Zhang; Long-Le Ma; Le-Xin Wang
Journal:  Exp Clin Cardiol       Date:  2013

7.  Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells.

Authors:  Sergey Zharikov; Karina Krotova; Hanbo Hu; Chris Baylis; Richard J Johnson; Edward R Block; Jawaharlal Patel
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-10       Impact factor: 4.249

8.  Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?

Authors:  Sergey I Zharikov; Erik R Swenson; Miguel Lanaspa; Edward R Block; Jawaharlal M Patel; Richard J Johnson
Journal:  Med Hypotheses       Date:  2010-01-12       Impact factor: 1.538

9.  Hyperuricemia and incident heart failure.

Authors:  Eswar Krishnan
Journal:  Circ Heart Fail       Date:  2009-08-06       Impact factor: 8.790

Review 10.  Uric acid in heart failure: a biomarker or therapeutic target?

Authors:  Marc Kaufman; Maya Guglin
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.